Spontaneous adverse event reports, albeit biased and incomplete data, remai
n very important and, frequently, are the sole data source to rely on durin
g the postmarketing phase for regulatory decision making. However, little p
rogress has been made in the past decade to improve the utility of these es
sential data. Further research that helps to improve our understanding of t
he extent and characteristics of adverse event reporting should be done to
ensure the maximum, appropriate utilization of this highly cost-efficient d
ata source. In addition, the authors challenge that research can and should
be done to advance our understanding of the behaviour and motivations of t
hose who report adverse events so as to improve the quality and the quantit
y of meaningful spontaneous adverse event reports. Copyright (C) 1999 John
Wiley & Sons, Ltd.